|
CCDC111 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.524300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.323200E-01 |
| Normal-vs-Stage2 |
8.995600E-01 |
| Normal-vs-Stage3 |
2.386200E-04 |
| Normal-vs-Stage4 |
1.022220E-03 |
| Stage1-vs-Stage2 |
6.840200E-01 |
| Stage1-vs-Stage3 |
5.725599999995E-05 |
| Stage1-vs-Stage4 |
5.649200E-04 |
| Stage2-vs-Stage3 |
1.021610E-02 |
| Stage2-vs-Stage4 |
1.250460E-02 |
| Stage3-vs-Stage4 |
9.811800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.867600E-02 |
| Normal-vs-AfricanAmerican |
1.935670E-03 |
| Normal-vs-Asian |
2.780400E-01 |
| Caucasian-vs-AfricanAmerican |
5.173900E-02 |
| Caucasian-vs-Asian |
1.059160E-01 |
| AfricanAmerican-vs-Asian |
2.328200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.899670E-02 |
| Normal-vs-Female |
9.789800E-02 |
| Male-vs-Female |
5.033600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.529900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.555000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.741580E-02 |
| Normal-vs-Age(81-100Yrs) |
2.594300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.689800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.593600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.574000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.037600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.136400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.828800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.076800E-01 |
| Normal-vs-Grade 2 |
8.493000E-01 |
| Normal-vs-Grade 3 |
1.298750E-03 |
| Normal-vs-Grade 4 |
4.12630000000691E-05 |
| Grade 1-vs-Grade 2 |
3.428400E-01 |
| Grade 1-vs-Grade 3 |
2.370200E-02 |
| Grade 1-vs-Grade 4 |
5.255500E-03 |
| Grade 2-vs-Grade 3 |
8.45890000000793E-05 |
| Grade 2-vs-Grade 4 |
3.69540000000335E-06 |
| Grade 3-vs-Grade 4 |
3.451900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.013600E-01 |
| Normal-vs-ccB subtype |
1.637400E-03 |
| ccA subtype-vs-ccB subtype |
2.23559999956713E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.231610E-01 |
| Normal-vs-N1 |
1.200800E-01 |
| N0-vs-N1 |
2.169400E-01 |
|
|
